A detailed history of Black Rock Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 17,619,937 shares of HALO stock, worth $827 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
17,619,937
Previous 18,241,548 3.41%
Holding current value
$827 Million
Previous $742 Million 24.33%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$37.81 - $52.4 $23.5 Million - $32.6 Million
-621,611 Reduced 3.41%
17,619,937 $923 Million
Q1 2024

May 10, 2024

SELL
$33.68 - $41.95 $13.1 Million - $16.3 Million
-389,415 Reduced 2.09%
18,241,548 $742 Million
Q4 2023

Feb 13, 2024

BUY
$33.32 - $42.1 $17.1 Million - $21.6 Million
512,348 Added 2.83%
18,630,963 $689 Million
Q3 2023

Nov 13, 2023

SELL
$36.46 - $44.03 $17.7 Million - $21.4 Million
-485,878 Reduced 2.61%
18,118,615 $692 Million
Q2 2023

Aug 11, 2023

BUY
$30.28 - $38.74 $13.9 Million - $17.8 Million
458,641 Added 2.53%
18,604,493 $671 Million
Q1 2023

May 12, 2023

SELL
$32.86 - $55.7 $2.3 Million - $3.89 Million
-69,874 Reduced 0.38%
18,145,852 $693 Million
Q4 2022

Feb 13, 2023

BUY
$40.06 - $59.44 $644,685 - $956,567
16,093 Added 0.09%
18,215,726 $1.04 Billion
Q3 2022

Nov 14, 2022

SELL
$38.53 - $51.78 $7 Million - $9.41 Million
-181,772 Reduced 0.99%
18,199,633 $720 Million
Q2 2022

Aug 12, 2022

SELL
$37.35 - $48.3 $48.1 Million - $62.3 Million
-1,288,820 Reduced 6.55%
18,381,405 $809 Million
Q1 2022

May 12, 2022

BUY
$31.97 - $41.06 $7.36 Million - $9.46 Million
230,362 Added 1.18%
19,670,225 $784 Million
Q4 2021

Feb 10, 2022

BUY
$31.82 - $40.75 $4.6 Million - $5.89 Million
144,483 Added 0.75%
19,439,863 $782 Million
Q3 2021

Nov 09, 2021

BUY
$38.47 - $46.42 $8.81 Million - $10.6 Million
228,942 Added 1.2%
19,295,380 $785 Million
Q2 2021

Aug 11, 2021

BUY
$38.84 - $51.31 $741 Million - $978 Million
19,066,438 New
19,066,438 $866 Million

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.54B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.